BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35933937)

  • 41. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
    Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
    JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
    Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
    Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low albumin-to-alkaline phosphatase ratio is associated with inferior prognosis in patients with head and neck cancer underwent concurrent chemoradiation: A propensity score-matched analysis.
    Kim D; Ki Y; Kim W; Park D; Joo J; Jeon H; Nam J
    J Cancer Res Ther; 2023; 19(5):1340-1344. PubMed ID: 37787305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.
    Ponce SEB; Erickson BA; Hall WA; Bedi M; Martens MJ; Siker M; Thomas J; George B; Ludwig K; Peterson C; Ridolfi T; Longo JM
    J Gastrointest Oncol; 2022 Feb; 13(1):185-196. PubMed ID: 35284138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
    Ajmani GS; Nocon CC; Wang CH; Bhayani MK
    Oral Oncol; 2017 Nov; 74():15-20. PubMed ID: 29103745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
    Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
    Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of radiographic extracapsular extension in locally advanced head and neck squamous cell cancers.
    Liu JT; Kann BH; De B; Buckstein M; Bakst RL; Genden EM; Posner MR; Som PM; Gupta V
    Oral Oncol; 2016 Jan; 52():52-7. PubMed ID: 26728104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study.
    Koulis TA; Kornaga EN; Banerjee R; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
    Clin Transl Radiat Oncol; 2017 Jun; 4():51-56. PubMed ID: 29594208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus and survival of patients with oropharyngeal cancer.
    Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
    N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer.
    Pajares B; Perez-Villa L; Trigo JM; Toledo MD; Alvarez M; Jimenez B; Medina JA; de Luque V; Jerez JM; Alba E
    Clin Transl Oncol; 2014 Apr; 16(4):418-24. PubMed ID: 24193865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
    Zhu X; Wang Y; Zhu H; Lou W
    Acta Otolaryngol; 2016 Dec; 136(12):1291-1298. PubMed ID: 27472193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Survival of Patients With T
    Zeng X; Peng L; Wen W; Sun W
    Laryngoscope; 2022 Jun; 132(6):1205-1212. PubMed ID: 34797566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An integrated model for prognosis in vulvar squamous cell carcinoma.
    Zhang T; Zhu Y; Luo J; Li J; Niu S; Chen H; Zhou F
    BMC Cancer; 2023 Jun; 23(1):534. PubMed ID: 37308869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.